| scholarly article | Q13442814 |
| P2093 | author name string | Ruebush TK | |
| Oloo AJ | |||
| Kazembe PN | |||
| Bloland PB | |||
| Barat LM | |||
| Himonga B | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chloroquine | Q422438 |
| Sub-Saharan Africa | Q132959 | ||
| P304 | page(s) | 543-552 | |
| P577 | publication date | 1998-07-01 | |
| P1433 | published in | Tropical Medicine and International Health | Q15765747 |
| P1476 | title | Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa | |
| P478 | volume | 3 |
| Q35147244 | A Piot model to analyse case management in malaria control programmes |
| Q39257146 | A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria |
| Q38881876 | Age, temperature, and parasitaemia predict chloroquine treatment failure and anaemia in children with uncomplicated Plasmodium falciparum malaria |
| Q35212414 | Antimalarial drug resistance and combination chemotherapy |
| Q39149127 | Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response |
| Q36945007 | Assessment of safety of the major antimalarial drugs |
| Q57230537 | Beyond evidence: a retrospective study of factors influencing a malaria treatment policy change in two South African provinces |
| Q39028593 | Changing the first line drug for malaria treatment--cost-effectiveness analysis with highly uncertain inter-temporal trade-offs. |
| Q36505813 | Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for uncomplicated malaria: a systematic review |
| Q40547428 | Chloroquine, sulfadoxine-pyrimethamine and amodiaquine efficacy for the treatment of uncomplicated Plasmodium falciparum malaria in Upper Nile, south Sudan |
| Q41920915 | Chloroquine- and sulfadoxine-pyrimethamine-resistant Falciparum malaria in vivo - a pilot study in rural Zambia. |
| Q39028600 | Cost-effectiveness of malaria control in sub-Saharan Africa. |
| Q55278873 | Cross sectional study to determine chloroquine resistance among Plasmodium falciparum clinical isolates from Khartoum, Sudan. |
| Q38983185 | Efficacy of chloroquine in the treatment of uncomplicated, Plasmodium falciparum malaria in northern Ghana |
| Q37117352 | Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali |
| Q41913496 | Efficacy of chloroquine, sulphadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county, Sudan. |
| Q34315195 | Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya |
| Q35545447 | History, dynamics, and public health importance of malaria parasite resistance |
| Q35013414 | Increasing antimalarial drug resistance in Uganda and revision of the national drug policy |
| Q35755266 | Media, health workers, and policy makers' relationship and their impact on antimalarial policy adoption: a population genetics perspective |
| Q34470236 | Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? |
| Q41921456 | Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children |
| Q41917325 | Sulphadoxine/pyrimethamine: an appropriate first-line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age. |
| Q51344705 | Superinfection and the evolution of resistance to antimalarial drugs. |
| Q36947762 | The anatomy of a malaria disaster: drug policy choice and mortality in African children |
| Q38885343 | The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda |
| Q38453822 | The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania. |
| Q38882426 | The efficacy of chloroquine, sulfadoxine-pyrimethamine and a combination of both for the treatment of uncomplicated Plasmodium falciparum malaria in an area of low transmission in western Uganda |
| Q41540119 | The rationale and plan for creating a World Antimalarial Resistance Network (WARN). |
| Q35838600 | Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy |
| Q34109430 | Using evidence to change antimalarial drug policy in Kenya |
Search more.